Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
LSE - Delayed Quote GBp

Nuformix plc (NFX.L)

Compare
0.1210
+0.0110
+(10.00%)
At close: April 4 at 4:35:18 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
9/30/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
--
--
--
50
195.5500
Cost of Revenue
--
--
--
1.6950
62.3070
Gross Profit
--
--
--
48.3050
133.2430
Operating Expense
506.3530
506.3530
--
1,318.5770
1,505.9210
Operating Income
-506.3530
-506.3530
--
-1,270.2720
-1,372.6780
Net Non Operating Interest Income Expense
--
--
--
--
-3.0540
Pretax Income
-3,647.0530
-3,647.0530
--
-1,270.2720
-1,375.7320
Tax Provision
-5.5660
-5.5660
--
-161.2790
-122.2350
Net Income Common Stockholders
-3,641.4870
-3,641.4870
--
-1,108.9930
-1,253.4970
Diluted NI Available to Com Stockholders
-3,641.4870
-3,641.4870
--
-1,108.9930
-1,253.4970
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
708,282.5190
786,932.3190
708,282.5190
598,447.7240
580,629.3720
Diluted Average Shares
708,282.5190
786,932.3190
708,282.5190
598,447.7240
580,629.3720
Total Operating Income as Reported
-3,647.0530
-3,647.0530
--
-1,270.2720
-1,372.6780
Total Expenses
506.3530
506.3530
--
1,320.2720
1,568.2280
Net Income from Continuing & Discontinued Operation
-3,641.4870
-3,641.4870
--
-1,108.9930
-1,253.4970
Normalized Income
2,635.1198
2,635.1198
--
-1,108.9930
-1,253.4970
Interest Expense
--
--
--
--
3.0540
Net Interest Income
--
--
--
--
-3.0540
EBIT
-506.3530
-506.3530
--
-1,270.2720
-1,372.6780
EBITDA
-477.1870
-477.1870
--
-1,233.2960
-1,279.6260
Reconciled Cost of Revenue
--
--
--
1.6950
62.3070
Reconciled Depreciation
29.1660
29.1660
--
36.9760
93.0520
Net Income from Continuing Operation Net Minority Interest
-3,641.4870
-3,641.4870
--
-1,108.9930
-1,253.4970
Total Unusual Items Excluding Goodwill
-3,140.7000
-3,140.7000
--
--
--
Normalized EBITDA
-477.1870
-477.1870
--
-1,233.2960
-1,279.6260
Tax Rate for Calcs
0
0
--
0.0001
0.0001
Tax Effect of Unusual Items
-4.7932
-4.7932
--
--
--
3/31/2021 - 12/17/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMM.L ImmuPharma plc
2.3750
-10.38%
 
IMTX Immatics N.V.
3.5000
-8.85%
 
HCWB HCW Biologics Inc.
0.2272
-4.82%
 
ADVM Adverum Biotechnologies, Inc.
3.8600
-2.03%
 
OLMA Olema Pharmaceuticals, Inc.
3.2500
-2.99%
 
CDT Conduit Pharmaceuticals Inc.
0.6457
-5.79%
 
BIVI BioVie Inc.
0.7750
-11.66%
 
IMVT Immunovant, Inc.
14.58
-7.60%
 
DNLI Denali Therapeutics Inc.
11.78
-7.90%
 
VERU Veru Inc.
0.5698
-2.00%